GlaxoSmithKline attempts to prevent arbitrage of its drug Combivir by selling different-colored pills in special bar-coded packages, to identify and track distributors in different markets.
False
True
True
GlaxoSmithKline implemented measures such as selling different-colored pills in special bar-coded packages to help prevent arbitrage of its drug Combivir. This strategy was aimed at tracking and identifying distributors in various markets to control the distribution and pricing of the medication.